Observational Study of Patients Undergoing Diagnostic Right Heart Catheterization
Recruiting · NCT07224906 · Observational (researchers observe without assigning treatment) · Lead sponsor: HemoCept Inc.
View the official record on ClinicalTrials.gov →What this trial is about
The objective of this observational pilot study is to collect HemoCept device data from subjects undergoing diagnostic right heart catheterization (RHC) procedures.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Subjects or representatives must have voluntarily signed the informed consent form before any study related procedures.
- Subjects can be any gender but must be age 18 or older.
- Subject is able and willing to provide informed consent and HIPAA authorization.
- Subject is able and willing to meet all study requirements.
- Scheduled for a diagnostic right heart catheterization (RHC-only or combined RHC+LHC; left-heart-only procedures are not eligible)
Exclusion criteria
- Subject is pregnant, breastfeeding, or intends to become pregnant during this study.
Where it is running
1 location listed across 1 US state.
- Boulder Heart - Boulder, Colorado, United States